Business Description
Abeona Therapeutics Inc
NAICS : 325413
SIC : 2834
ISIN : US00289Y1073
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.69 | |||||
Equity-to-Asset | -0.12 | |||||
Debt-to-Equity | -2.61 | |||||
Debt-to-EBITDA | -0.32 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -15.81 | |||||
Beneish M-Score | -0.96 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -60.7 | |||||
3-Year EBITDA Growth Rate | 51 | |||||
3-Year EPS without NRI Growth Rate | 47.3 | |||||
3-Year FCF Growth Rate | 43.7 | |||||
3-Year Book Growth Rate | -72.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.14 | |||||
9-Day RSI | 35.66 | |||||
14-Day RSI | 37.05 | |||||
6-1 Month Momentum % | -23.63 | |||||
12-1 Month Momentum % | 5.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.61 | |||||
Quick Ratio | 5.61 | |||||
Cash Ratio | 5.24 | |||||
Days Sales Outstanding | 365 | |||||
Days Payable | 643.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -90.4 | |||||
Shareholder Yield % | -27.46 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.14 | |||||
Operating Margin % | -1442.63 | |||||
Net Margin % | -2190.26 | |||||
FCF Margin % | -1160.35 | |||||
ROE % | -683.63 | |||||
ROA % | -122.93 | |||||
ROIC % | -405.19 | |||||
ROC (Joel Greenblatt) % | -847.71 | |||||
ROCE % | -144.3 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 20.93 | |||||
EV-to-EBIT | -1.7 | |||||
EV-to-EBITDA | -1.77 | |||||
EV-to-Revenue | 36.58 | |||||
EV-to-Forward-Revenue | 20.51 | |||||
EV-to-FCF | -3.15 | |||||
Earnings Yield (Greenblatt) % | -58.82 | |||||
FCF Yield % | -24.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Abeona Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3.231 | ||
EPS (TTM) (€) | -2.953 | ||
Beta | 0.2 | ||
Volatility % | 93.11 | ||
14-Day RSI | 37.05 | ||
14-Day ATR (€) | 0.258753 | ||
20-Day SMA (€) | 3.88 | ||
12-1 Month Momentum % | 5.34 | ||
52-Week Range (€) | 2.636 - 8.165 | ||
Shares Outstanding (Mil) | 41.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Abeona Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Abeona Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Abeona Therapeutics Inc Frequently Asked Questions
What is Abeona Therapeutics Inc(STU:PCJ)'s stock price today?
When is next earnings date of Abeona Therapeutics Inc(STU:PCJ)?
Does Abeona Therapeutics Inc(STU:PCJ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |